For the year ending 2025-12-31, ABEO has $219,570K in assets. $60,354K in debts. $78,437K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 78,437 | |||
| Short-term investments | 112,967 | |||
| Accounts receivable, net | 6,147 | |||
| Inventory | 5,493 | |||
| Other receivables | 568 | |||
| Prepaid expenses and other current assets | 1,294 | |||
| Total current assets | 204,906 | |||
| Subtotal | 27,139 | |||
| Less accumulated depreciation | 17,218 | |||
| Property and equipment, net | 9,921 | |||
| Operating lease right-of-use assets | 3,962 | |||
| Other assets | 781 | |||
| Total assets | 219,570 | |||
| Accounts payable | 7,889 | |||
| Accrued expenses | 8,467 | |||
| Current portion of long-term debt | 12,222 | |||
| Current portion of operating lease liability | 864 | |||
| Accrued taxes | 126 | |||
| Other current liabilities | 2 | |||
| Total current liabilities | 29,570 | |||
| Long-term operating lease liabilities | 4,069 | |||
| Long-term debt | 7,813 | |||
| Warrant liabilities | 18,902 | |||
| Total liabilities | 60,354 | |||
| Common stock - 0.01 par value authorized 200,000,000 shares 55,043,413 and 45,644,091 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 550 | |||
| Additional paid-in capital | 900,603 | |||
| Accumulated deficit | -742,075 | |||
| Accumulated other comprehensive loss | 138 | |||
| Total stockholders equity | 159,216 | |||
| Total liabilities and stockholders equity | 219,570 | |||
ABEONA THERAPEUTICS INC. (ABEO)
ABEONA THERAPEUTICS INC. (ABEO)